Abstract:BackgroundSevere traumatic brain injury (TBI) is a major contributor to disability and mortality in the industrialized world. Outcomes of severe TBI are profoundly heterogeneous, complicating outcome prognostication. Several prognostic models have been validated for acute prediction of 6-month global outcomes following TBI (e.g., morbidity/mortality). In this preliminary observational prognostic study, we assess the utility of the International Mission on Prognosis and Analysis of Clinical Trials in TBI (IMPACT) Lab model in predicting longer term global and cognitive outcomes (7–10 years post injury) and the extent to which cerebrospinal fluid (CSF) biomarkers enhance outcome prediction.MethodsVery long-term global outcome was assessed in a total of 59 participants (41 of whom did not survive their injuries) using the Glasgow Outcome Scale-Extended and Disability Rating Scale. More detailed outcome information regarding cognitive functioning in daily life was collected from 18 participants surviving to 7–10 years post injury using the Cognitive Subscale of the Functional Independence Measure. A subset (n = 10) of these participants also completed performance-based cognitive testing (Digit Span Test) by telephone. The IMPACT lab model was applied to determine its prognostic value in relation to very long-term outcomes as well as the additive effects of acute CSF ubiquitin C-terminal hydrolase-L1 (UCH-L1) and microtubule associated protein 2 (MAP-2) concentrations.ResultsThe IMPACT lab model discriminated favorable versus unfavorable 7- to 10-year outcome with an area under the receiver operating characteristic curve of 0.80. Higher IMPACT lab model risk scores predicted greater extent of very long-term morbidity (β = 0.488 p = 0.000) as well as reduced cognitive independence (β = − 0.515, p = 0.034). Acute elevations in UCH-L1 levels were also predictive of lesser independence in cognitive activities in daily life at very long-term follow-up (β = 0.286, p = 0.048). Addition of two CSF biomarkers significantly improved prediction of very long-term neuropsychological performance among survivors, with the overall model (including IMPACT lab score, UCH-L1, and MAP-2) explaining 89.6% of variance in cognitive performance 7–10 years post injury (p = 0.008). Higher acute UCH-L1 concentrations were predictive of poorer cognitive performance (β = − 0.496, p = 0.029), whereas higher acute MAP-2 concentrations demonstrated a strong cognitive protective effect (β = 0.679, p = 0.010).ConclusionsAlthough preliminary, results suggest that existing prognostic models, including models with incorporation of CSF markers, may be applied to predict outcome of severe TBI years after injury. Continued research is needed examining early predictors of longer-term outcomes following TBI to identify potential targets for clinical trials that could impact long-ranging functional and cognitive outcomes.

The mini-mental state examination and the montreal cognitive assessment after traumatic brain injury: An early predictive study

Evaluation of models that predict short-term outcome after traumatic brain injury

Serial Mini-Mental Status Examination to Evaluate Cognitive Outcome in Patients with Traumatic Brain Injury

Montreal cognitive assessment for cognitive detection in brain trauma patients with normal mini-mental state examination scores

Evaluation of the Mini-Mental State Examination and the Montreal Cognitive Assessment for Predicting Post-stroke Cognitive Impairment During the Acute Phase in Chinese Minor Stroke Patients

Enhancing Hospital Course and Outcome Prediction in Patients with Traumatic Brain Injury: A Machine Learning Study.

Predictive utility of an adapted Marshall head CT classification scheme after traumatic brain injury

The reliability and validity of brief cognitive screening tools used in traumatic brain injury: A systematic review

Factors Influencing Objective and Subjective Prospective Memory Measures in Traumatic Brain Injury

Cognitive-communication skills and acute outcome following mild traumatic brain injury

The minimally conscious state and recovery potential: A follow-up study 2 to 5 years after traumatic brain injury

Determining client cognitive status following mild traumatic brain injury

The Use of MMSE and MoCA in Patients with Acute Ischemic Stroke in Clinical

Predicting Clinical Outcomes 7–10 Years after Severe Traumatic Brain Injury: Exploring the Prognostic Utility of the IMPACT Lab Model and Cerebrospinal Fluid UCH-L1 and MAP-2

Cognitive assessment to optimize prediction of functional outcome in subacute hip fracture: a short-term prospective study

A Multi-Modal Assessment of Clinical Predictors for Traumatic Brain Injury End-Points

Predictors of short-term outcome in brain-injured patients with disorders of consciousness

Predicting Neurological Deterioration after Moderate Traumatic Brain Injury: Development and Validation of a Prediction Model Based on Data Collected on Admission

Multimodal magnetic resonance imaging characterizes clinical outcome in chronic traumatic brain injury

Diagnostic Accuracy of Mental Health Screening Tools After Mild Traumatic Brain Injury

Predictive Models of Long-Term Outcome in Patients with Moderate to Severe Traumatic Brain Injury are Biased Toward Mortality Prediction